Atlas Trials

Evaluation of CAR19 T-cells as an Optimal Bridge to Allogeneic Transplantation

Clinical trial NCT02431988 · COMPLETED

Trial details

NCT number
NCT02431988
Sponsor
University College, London
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Diffuse Large B-Cell Lymphoma
Start date
2016-06-01
Primary completion
2020-02-02
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.